Sfoglia per Autore
Oral multikinase inhibitor regorafenib for the treatment of patients with metastatic colorectal cancer
2013-01-01 Falcone, Alfredo; Cremolini, Chiara; Schirripa, Marta; Loupakis, Fotios
Reply: Comment on 'Histopathologic evaluation of liver metastases from colorectal cancer patients treated with FOLFOXIRI plus bevacizumab'
2013-01-01 Schirripa, Marta; Loupakis, Fotios; Pollina, L.; Cremolini, Chiara; Pasquini, G.; Falcone, Alfredo
DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: Pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer.
2015-01-01 Cremolini, Chiara; DEL RE, Marzia; Loupakis, Fotios; Marmorino, F.; Citi, Valentina; Palombi, M.; Bergamo, F.; Schirripa, Marta; Rossini, D.; Cortesi, E.; Tomasello, G.; Spadi, R.; Buonadonna, A.; Amoroso, D.; Vitello, S.; Di Donato, S.; Granetto, C.; D'Amico, M.; Falcone, Alfredo; Danesi, Romano
KRAS status and risk of venous thromboembolic events in patients with metastatic colorectal cancer: a case-control study.
2015-01-01 Rihawi, K.; Fontanella, C.; Rossini, D.; Schirripa, Marta; De Carlo, E.; Salvatore, Lisa; Ongaro, E.; Casagrande, M.; Ferrai, L.; Pella, N.; Cardellino, G. G.; Giovannoni, M.; Iaiza, E.; Ermacora, P.; Puglisi, F.; Loupakis, Fotios; Falcone, Alfredo; Pisa, F. E.; Aprile, G.; Fasola, G.
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer
2015-01-01 Schirripa, Marta; Cremolini, Chiara; Loupakis, Fotios; Morvillo, Manfredi; Bergamo, Francesca; Zoratto, Federica; Salvatore, Lisa; Antoniotti, Carlotta; Marmorino, Federica; Sensi, Elisa; Lupi, Cristiana; Fontanini, Gabriella; Gregorio, Veronica De; Giannini, Riccardo; Basolo, Fulvio; Masi, Gianluca; Falcone, Alfredo
Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
2015-01-01 Antoniotti, C.; Loupakis, Fotios; Schirripa, Marta; Cremolini, Chiara; Poliseno, L.; Salvatore, Lisa; Tuccoli, A.; D'Aurizio, R.; Marmorino, F.; Borelli, B.; Rossini, D.; Saettini, A.; Gini, S.; Moretto, Roberto; Rizzo, I.; Dell'Aquila, E.; Pellegrini, M.; Falcone, Alfredo
First-line chemotherapy for mCRC-a review and evidence-based algorithm
2015-01-01 Cremolini, Chiara; Schirripa, Marta; Antoniotti, Carlotta; Moretto, Roberto; Salvatore, Lisa; Masi, Gianluca; Falcone, Alfredo; Loupakis, Fotios
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer
2015-01-01 Loupakis, Fotios; Moretto, Roberto; Aprile, Giuseppe; Muntoni, Marta; Cremolini, Chiara; Iacono, Donatella; Casagrande, Mariaelena; Ferrari, Laura; Salvatore, Lisa; Schirripa, Marta; Rossini, Daniele; de Maglio, Giovanna; Fasola, Gianpiero; Calvetti, Lorenzo; Pilotto, Sara; Carbognin, Luisa; Fontanini, Gabriella; Tortora, Giampaolo; Falcone, Alfredo; Sperduti, Isabella; Bria, Emilio
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
2015-01-01 Schirripa, Marta; Bergamo, F.; Cremolini, Chiara; Casagrande, M.; Lonardi, Sara; Aprile, G.; Yang, D.; Marmorino, Federica; Pasquini, G.; Sensi, E.; Lupi, C.; De Maglio, G.; Borrelli, Nicla; Pizzolitto, S.; Fasola, G.; Bertorelle, R.; Rugge, M.; Fontanini, Gabriella; Zagonel, V.; Loupakis, Fotios; Falcone, Alfredo
TAS-102 for the treatment of metastatic colorectal cancer
2015-01-01 Salvatore, Lisa; Rossini, Daniele; Moretto, Roberto; Cremolini, Chiara; Schirripa, Marta; Antoniotti, Carlotta; Marmorino, Federica; Loupakis, Fotios; Falcone, Alfredo; Masi, Gianluca
Phase II study of single-agent cetuximab in KRAS g13d mutant metastatic colorectal cancer
2015-01-01 Schirripa, Marta; Loupakis, Fotios; Lonardi, Sara; Cremolini, Chiara; Bergamo, F.; Zagonel, V.; Falcone, Alfredo
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: Final results of the randomized BEBYP trial
2015-01-01 Falcone, A.; Salvatore, L.; Boni, L.; Loupakis, F.; Cremolini, C.; Fornaro, L.; Schirripa, M.; Cupini, Stefano; Barbara, C.; Safina, V.; Granetto, C.; Fea, E.; Antonuzzo, L.; Boni, C.; Allegrini, G.; Chiara, S.; Amoroso, D.; Bonetti, A.
Clinical significance of tlr1 i602s polymorphism for patients with metastatic colorectal cancer treated with folfiri plus bevacizumab
2016-01-01 Okazaki, Satoshi; Loupakis, Fotios; Stintzing, Sebastian; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Sunakawa, Yu; Stremitzer, Stefan; Matsusaka, Satoshi; Berger, Martin D.; Parekh, Anish; West, Jordan D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; Depaolo, R. William; Lenz, Heinz Josef
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer
2017-01-01 Suenaga, M; Schirripa, M; Cao, S; Zhang, W; Yang, D; Murgioni, S; Rossini, D; Marmorino, F; Mennitto, A; Ning, Y; Okazaki, S; Berger, M D; Miyamoto, Y; Gopez, R; Barzi, A; Yamaguchi, T; Loupakis, F; Lenz, H-J
Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
2017-01-01 Okazaki, Satoshi; Schirripa, Marta; Loupakis, Fotios; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Berger, Martin D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Iqubal, Syma; Barzi, Afsaneh; Cremolini, Chiara; Falcone, Alfredo; Battaglin, Francesca; Salvatore, Lisa; Borelli, Beatrice; Helentjaris, Timothy G.; Lenz, Heinz josef
Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials
2017-01-01 Berger, Martin D; Yamauchi, Shinichi; Cao, Shu; Hanna, Diana L.; Sunakawa, Yu; Schirripa, Marta; Matsusaka, Satoshi; Yang, Dongyun; Groshen, Susan; Zhang, Wu; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Lonardi, Sara; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; Loupakis, Fotios; Stintzing, Sebastian; Lenz, Heinz Josef
Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 and TRIBE trials
2017-01-01 Berger, M. D.; Stintzing, S.; Heinemann, V.; Yang, D.; Cao, S.; Sunakawa, Y.; Ning, Y.; Matsusaka, S.; Okazaki, S.; Miyamoto, Y.; Suenaga, M.; Schirripa, M.; Soni, S.; Zhang, W.; Falcone, A.; Loupakis, F.; Lenz, H. -. J.
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study
2017-01-01 Cremolini, Chiara; Pietrantonio, F; Tomasello, G; Dadduzio, V; Morett, R; Morano, F; Schirripa, Marta; Antoniotti, Carlotta; Fucà, G; Bergamo, F; Rossini, Daniele; Nichetti, F; Ziampiri, S; Ghidini, M; Marmorino, Federica; Prisciandaro, M; Falcone, Alfredo; De Braud, F; Loupakis, Fotios; Lonardi, S.
Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial
2017-01-01 Schirripa, Marta; Zhang, Wu; Heinemann, Volker; Cao, Shu; Okazaki, Satoshi; Yang, Dongyun; Loupakis, Fotios; Berger, Martin D.; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Gopez, Roel F.; West, Jordan D.; Hanna, Diana; Barzi, Afsaneh; Falcone, Alfredo; Stintzing, Sebastian; Lenz, Heinz-Josef
TRIBE-2: A phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group
2017-01-01 Cremolini, Chiara; Marmorino, Federica; Loupakis, Fotios; Masi, Gianluca; Antoniotti, Carlotta; Salvatore, Lisa; Schirripa, Marta; Boni, Luca; Zagonel, Vittorina; Lonardi, Sara; Aprile, Giuseppe; Tamburini, Emiliano; Ricci, Vincenzo; Ronzoni, Monica; Pietrantonio, Filippo; Valsuani, Chiara; Tomasello, Gianluca; Passardi, Alessandro; Allegrini, Giacomo; DI DONATO, Samantha; Santini, Daniele; Falcone, Alfredo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Oral multikinase inhibitor regorafenib for the treatment of patients with metastatic colorectal cancer | 1-gen-2013 | Falcone, Alfredo; Cremolini, Chiara; Schirripa, Marta; Loupakis, Fotios | |
| Reply: Comment on 'Histopathologic evaluation of liver metastases from colorectal cancer patients treated with FOLFOXIRI plus bevacizumab' | 1-gen-2013 | Schirripa, Marta; Loupakis, Fotios; Pollina, L.; Cremolini, Chiara; Pasquini, G.; Falcone, Alfredo | |
| DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: Pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer. | 1-gen-2015 | Cremolini, Chiara; DEL RE, Marzia; Loupakis, Fotios; Marmorino, F.; Citi, Valentina; Palombi, M.; Bergamo, F.; Schirripa, Marta; Rossini, D.; Cortesi, E.; Tomasello, G.; Spadi, R.; Buonadonna, A.; Amoroso, D.; Vitello, S.; Di Donato, S.; Granetto, C.; D'Amico, M.; Falcone, Alfredo; Danesi, Romano | |
| KRAS status and risk of venous thromboembolic events in patients with metastatic colorectal cancer: a case-control study. | 1-gen-2015 | Rihawi, K.; Fontanella, C.; Rossini, D.; Schirripa, Marta; De Carlo, E.; Salvatore, Lisa; Ongaro, E.; Casagrande, M.; Ferrai, L.; Pella, N.; Cardellino, G. G.; Giovannoni, M.; Iaiza, E.; Ermacora, P.; Puglisi, F.; Loupakis, Fotios; Falcone, Alfredo; Pisa, F. E.; Aprile, G.; Fasola, G. | |
| Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer | 1-gen-2015 | Schirripa, Marta; Cremolini, Chiara; Loupakis, Fotios; Morvillo, Manfredi; Bergamo, Francesca; Zoratto, Federica; Salvatore, Lisa; Antoniotti, Carlotta; Marmorino, Federica; Sensi, Elisa; Lupi, Cristiana; Fontanini, Gabriella; Gregorio, Veronica De; Giannini, Riccardo; Basolo, Fulvio; Masi, Gianluca; Falcone, Alfredo | |
| Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib | 1-gen-2015 | Antoniotti, C.; Loupakis, Fotios; Schirripa, Marta; Cremolini, Chiara; Poliseno, L.; Salvatore, Lisa; Tuccoli, A.; D'Aurizio, R.; Marmorino, F.; Borelli, B.; Rossini, D.; Saettini, A.; Gini, S.; Moretto, Roberto; Rizzo, I.; Dell'Aquila, E.; Pellegrini, M.; Falcone, Alfredo | |
| First-line chemotherapy for mCRC-a review and evidence-based algorithm | 1-gen-2015 | Cremolini, Chiara; Schirripa, Marta; Antoniotti, Carlotta; Moretto, Roberto; Salvatore, Lisa; Masi, Gianluca; Falcone, Alfredo; Loupakis, Fotios | |
| Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer | 1-gen-2015 | Loupakis, Fotios; Moretto, Roberto; Aprile, Giuseppe; Muntoni, Marta; Cremolini, Chiara; Iacono, Donatella; Casagrande, Mariaelena; Ferrari, Laura; Salvatore, Lisa; Schirripa, Marta; Rossini, Daniele; de Maglio, Giovanna; Fasola, Gianpiero; Calvetti, Lorenzo; Pilotto, Sara; Carbognin, Luisa; Fontanini, Gabriella; Tortora, Giampaolo; Falcone, Alfredo; Sperduti, Isabella; Bria, Emilio | |
| BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection | 1-gen-2015 | Schirripa, Marta; Bergamo, F.; Cremolini, Chiara; Casagrande, M.; Lonardi, Sara; Aprile, G.; Yang, D.; Marmorino, Federica; Pasquini, G.; Sensi, E.; Lupi, C.; De Maglio, G.; Borrelli, Nicla; Pizzolitto, S.; Fasola, G.; Bertorelle, R.; Rugge, M.; Fontanini, Gabriella; Zagonel, V.; Loupakis, Fotios; Falcone, Alfredo | |
| TAS-102 for the treatment of metastatic colorectal cancer | 1-gen-2015 | Salvatore, Lisa; Rossini, Daniele; Moretto, Roberto; Cremolini, Chiara; Schirripa, Marta; Antoniotti, Carlotta; Marmorino, Federica; Loupakis, Fotios; Falcone, Alfredo; Masi, Gianluca | |
| Phase II study of single-agent cetuximab in KRAS g13d mutant metastatic colorectal cancer | 1-gen-2015 | Schirripa, Marta; Loupakis, Fotios; Lonardi, Sara; Cremolini, Chiara; Bergamo, F.; Zagonel, V.; Falcone, Alfredo | |
| Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: Final results of the randomized BEBYP trial | 1-gen-2015 | Falcone, A.; Salvatore, L.; Boni, L.; Loupakis, F.; Cremolini, C.; Fornaro, L.; Schirripa, M.; Cupini, Stefano; Barbara, C.; Safina, V.; Granetto, C.; Fea, E.; Antonuzzo, L.; Boni, C.; Allegrini, G.; Chiara, S.; Amoroso, D.; Bonetti, A. | |
| Clinical significance of tlr1 i602s polymorphism for patients with metastatic colorectal cancer treated with folfiri plus bevacizumab | 1-gen-2016 | Okazaki, Satoshi; Loupakis, Fotios; Stintzing, Sebastian; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Sunakawa, Yu; Stremitzer, Stefan; Matsusaka, Satoshi; Berger, Martin D.; Parekh, Anish; West, Jordan D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; Depaolo, R. William; Lenz, Heinz Josef | |
| Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer | 1-gen-2017 | Suenaga, M; Schirripa, M; Cao, S; Zhang, W; Yang, D; Murgioni, S; Rossini, D; Marmorino, F; Mennitto, A; Ning, Y; Okazaki, S; Berger, M D; Miyamoto, Y; Gopez, R; Barzi, A; Yamaguchi, T; Loupakis, F; Lenz, H-J | |
| Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer | 1-gen-2017 | Okazaki, Satoshi; Schirripa, Marta; Loupakis, Fotios; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Berger, Martin D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Iqubal, Syma; Barzi, Afsaneh; Cremolini, Chiara; Falcone, Alfredo; Battaglin, Francesca; Salvatore, Lisa; Borelli, Beatrice; Helentjaris, Timothy G.; Lenz, Heinz josef | |
| Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials | 1-gen-2017 | Berger, Martin D; Yamauchi, Shinichi; Cao, Shu; Hanna, Diana L.; Sunakawa, Yu; Schirripa, Marta; Matsusaka, Satoshi; Yang, Dongyun; Groshen, Susan; Zhang, Wu; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Lonardi, Sara; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; Loupakis, Fotios; Stintzing, Sebastian; Lenz, Heinz Josef | |
| Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 and TRIBE trials | 1-gen-2017 | Berger, M. D.; Stintzing, S.; Heinemann, V.; Yang, D.; Cao, S.; Sunakawa, Y.; Ning, Y.; Matsusaka, S.; Okazaki, S.; Miyamoto, Y.; Suenaga, M.; Schirripa, M.; Soni, S.; Zhang, W.; Falcone, A.; Loupakis, F.; Lenz, H. -. J. | |
| Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study | 1-gen-2017 | Cremolini, Chiara; Pietrantonio, F; Tomasello, G; Dadduzio, V; Morett, R; Morano, F; Schirripa, Marta; Antoniotti, Carlotta; Fucà, G; Bergamo, F; Rossini, Daniele; Nichetti, F; Ziampiri, S; Ghidini, M; Marmorino, Federica; Prisciandaro, M; Falcone, Alfredo; De Braud, F; Loupakis, Fotios; Lonardi, S. | |
| Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial | 1-gen-2017 | Schirripa, Marta; Zhang, Wu; Heinemann, Volker; Cao, Shu; Okazaki, Satoshi; Yang, Dongyun; Loupakis, Fotios; Berger, Martin D.; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Gopez, Roel F.; West, Jordan D.; Hanna, Diana; Barzi, Afsaneh; Falcone, Alfredo; Stintzing, Sebastian; Lenz, Heinz-Josef | |
| TRIBE-2: A phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group | 1-gen-2017 | Cremolini, Chiara; Marmorino, Federica; Loupakis, Fotios; Masi, Gianluca; Antoniotti, Carlotta; Salvatore, Lisa; Schirripa, Marta; Boni, Luca; Zagonel, Vittorina; Lonardi, Sara; Aprile, Giuseppe; Tamburini, Emiliano; Ricci, Vincenzo; Ronzoni, Monica; Pietrantonio, Filippo; Valsuani, Chiara; Tomasello, Gianluca; Passardi, Alessandro; Allegrini, Giacomo; DI DONATO, Samantha; Santini, Daniele; Falcone, Alfredo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile